May 10, 2006
Cardinal Health to test next phase of e2e RFID technology in pilot program
In order to improve the safety and efficiency of the nation's drug supply, Cardinal Health, Inc., has decided to start next phase of end-to-end pilot program to test RFID technology. Under this program, the company will begin to tag medication with labels which carries unique data. These data can be captured and read to verify its authenticity at each step of the supply chain. In this way, the company can check counterfeit of drug entering the supply chain.
Renard Jackson, executive vice president of packaging services for Cardinal Health said,
Cardinal Health is the first company in health care to comprehensively test RFID technology at the unit level in a real-time setting, beginning with product labeling and packaging, and then as it travels through the distribution center to when it is received by a customer.
The use of RFID technology will benefit drug manufacturers, pharmacists and consumers.
Via: [Yahoo! Biz]
--
Did you enjoy this post?
« Printronix completes RFID trial with Virgin Atlantic Airways | Main | Weber acquires Gen 2 RFID »
